Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization

Oh, A.-R., Jeong, Y., Yu, J., Minh Tam, D. T., Kang, J. K., Jung, Y. H., Im, S.-S., Lee, S. B., Ryu, D., Pajvani, U. B., & Kim, K. (2023). Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization. Gastroenterology, 164(3), 439–453. https://doi.org/10.1053/j.gastro.2022.11.019
Authors:
Ah-Reum Oh
Yelin Jeong
Junjie Yu
Dao Thi Minh Tam
Jin Ku Kang
Young Hoon Jung
Seung-Soon Im
Sang Bae Lee
Dongryeol Ryu
Utpal B Pajvani
KyeongJin Kim
Affiliated Authors:
Junjie Yu
Jin Ku Kang
Utpal B Pajvani
Author Keywords:
chrebp
kctd17
nafld
type 2 diabetes
Publication Type:
Article
Unique ID:
10.1053/j.gastro.2022.11.019
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: